Trade Summary

5 days ago, Zeiher Bernhardt G, serving as Dir at Entrada Therapeutics, Inc. (TRDA), purchased 5,000 shares at $5.86 per share, for a total transaction value of $29,316.00. Following this transaction, Zeiher Bernhardt G now holds 5,000 shares of TRDA.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 4:31 PM ET, 1 day after the trade was made.

Entrada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.